Skip to search.
 TSX Up 0.47% TSX Ventures Up 1.46%

Geron Corporation (GERN)

-NasdaqGS
2.95 Down 0.09(2.96%) 4:00PM EDT
|After Hours : 2.95 0.00 (0.00%) 7:37PM EDT
Prev Close:3.04
Open:3.04
Bid:2.94 x 4400
Ask:2.95 x 4300
1y Target Est:7.50
Beta:2.98355
Next Earnings Date: 5-May-16GERN Earnings announcement
Day's Range:2.94 - 3.10
52wk Range:2.30 - 5.30
Volume:1,829,805
Avg Vol (3m):2,426,730
Market Cap:468.81M
P/E (ttm):N/A
EPS (ttm):0.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNDown 2.96%468.81M
BMYDown 0.11%120.73B
GSKDown 1.04%103.84B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.23
Quarterly EPS Est (Mar-16) :-0.06
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-2.64

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback